1-2 of 2
Nina Shah
Close
Sort by
Journal Articles

CAR T-cell therapy: is it prime time in myeloma?

Surbhi Sidana, Nina Shah
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 260–265.
https://doi.org/10.1182/hematology.2019000370
Published: 2019
Journal Articles

Evidence-Based Mini-Review: Treatment Options for Patients with Relapsed/Refractory Myeloma Previously Treated with Novel Agents and High-Dose Chemotherapy and Autologous Stem-Cell Transplantation

Nina Shah, Sagar Lonial
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 310–313.
https://doi.org/10.1182/asheducation-2010.1.310
Published: 2010